Literature DB >> 9673307

Improved tumor staging in colorectal cancer.

A Lindblom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9673307     DOI： 10.1056/NEJM199807233390410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Ex vivo sentinel node mapping in carcinoma of the colon and rectum.

Authors:  J H Wong; S Steineman; C Calderia; J Bowles; T Namiki
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

2.  Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.

Authors:  S L Kong; M Salto-Tellez; A P K Leong; Y H Chan; E S C Koay
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

3.  Previstage GCC test for staging patients with colorectal cancer.

Authors:  Alex Mejia; Scott A Waldmana
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

4.  Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Kai Hermann; Alexander Rehders; Claus F Eisenberger; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

5.  Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater.

Authors:  P Scheunemann; N H Stoecklein; A Rehders; M Bidde; S Metz; M Peiper; C Eisenberger; J Schulte Am Esch; W T Knoefel; S B Hosch
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

6.  Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Alexander Rehders; Minu Bidde; Sylvia Metz; Matthias Peiper; Claus F Eisenberger; Jan Schulte Am Esch; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2007-08-18       Impact factor: 3.445
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.